BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 20, Issue 18
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (19666)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.
Item 
Count 
PDF1916
WORD339
HTML15346
Figures (1-1)131
Tables (1-3)138
 Sum=17870
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse978
Download818
 Sum=1796
May 14, 2014 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Yang JC, Lu CW, Lin CJ. Treatment of Helicobacter pylori infection: Current status and future concepts. World J Gastroenterol 2014; 20(18): 5283-5293 [PMID: 24833858 DOI: 10.3748/wjg.v20.i18.5283]
URL: https://www.wjgnet.com/1007-9327/full/v20/i18/5283.htm
Number Citing Articles
1
Hassan Salmanroghani, Massoud Mirvakili, Mahmud Baghbanian, Roham Salmanroghani, Golshid Sanati, Pouria Yazdian, John Green. Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial. PLOS ONE 2018; 13(6): e0197096 doi: 10.1371/journal.pone.0197096
2
Marco Gasparetto, Caterina Strisciuglio, Amit Assa, Kostantinos Gerasimidis, Federica Giachero, Jan Novak, Philip Robinson, Bálint Tél, Matthias Zilbauer, Andreas Jenke. Making Research Flourish Through ESPGHAN. Journal of Pediatric Gastroenterology and Nutrition 2022; 74(2): 301 doi: 10.1097/MPG.0000000000003250
3
Patrick Joseph Tempera, Mark Michael, Omar Tageldin, Stephen Hasak. Gastric Cancer Due to Chronic H. pylori Infection: What We Know and Where We Are Going. Diseases 2022; 10(3): 57 doi: 10.3390/diseases10030057
4
Assessment of Drug Treatment Practices and Pattern for Gastroenteritis Among Under-Five Children in A Tertiary Hospital in Southeast Nigeria. International Journal of Pharmacy and Infections Therapy 2021; : 1 doi: 10.31829/2765-852X/ijpit2021-4(1)-118
5
Dian Wang, Dafeng Wang, Kai Liao, Biqi Zhang, Shuai Li, Minghui Liu, Linjie Lv, Feng Xue. Optical detection using CRISPR-Cas12a of Helicobacter pylori for veterinary applications. Microchimica Acta 2023; 190(11) doi: 10.1007/s00604-023-06037-x
6
Seong Ju Lee, Yun Jeong Lim, Seok Bo Hong, Ji Hyung Nam, Dong Kee Jang, Hyoun Woo Kang, Jae Hak Kim, Jun Kyu Lee, Moon-Su Koh, Jin Ho Lee. Standard First-line Triple Therapy for Helicobacter pylori Infection: A Comparison of Eradication Rates Based on Timing of Administration of Proton Pump Inhibitors. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2018; 18(2): 115 doi: 10.7704/kjhugr.2018.18.2.115
7
Hassan Seddik, Jihane Benass, Sanaa Berrag, Asmae Sair, Reda Berraida, Hanae Boutallaka. Optimized sequential therapy <i>vs</i> 10- and 14-d concomitant therapy for eradicating <i>Helicobacter pylori</i>: A randomized clinical trial. World Journal of Gastroenterology 2024; 30(6): 556-564 doi: 10.3748/wjg.v30.i6.556
8
Andrés González, Sandra Salillas, Adrián Velázquez-Campoy, Vladimir Espinosa Angarica, María F. Fillat, Javier Sancho, Ángel Lanas. Identifying potential novel drugs against Helicobacter pylori by targeting the essential response regulator HsrA. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-47746-9
9
Peiyu Chen, Linkai Li, Hongli Wang, Junhong Zhao, Yang Cheng, Jing Xie, Meiwan Cao, Ling Huang, Fangying Yang, Huan Chen, Jiayu Chen, Mingmin Su, Yuxin Xu, Fengfeng Zheng, Lanlan Geng, Wanfu Xu, Sitang Gong. Omeprazole, an inhibitor of proton pump, suppresses De novo lipogenesis in gastric epithelial cells. Biomedicine & Pharmacotherapy 2020; 130: 110472 doi: 10.1016/j.biopha.2020.110472
10
Elianna Dunster, William L. Johnson, Rachel A. F. Wozniak. Antimicrobial Drug–Drug Interactions in the Treatment of Infectious Keratitis. Cornea 2023; 42(12): 1555 doi: 10.1097/ICO.0000000000003304
11
Cailing Li, Yanyan Shi, Baojun Suo, Xueli Tian, Liya Zhou, Zhiqiang Song. PPI‐amoxicillin dual therapy four times daily is superior to guidelines recommended regimens in the Helicobacter pylori eradication therapy within Asia: A systematic review and meta‐analysis. Helicobacter 2021; 26(4) doi: 10.1111/hel.12816
12
Lucas Mainardo Rodrigues Bezerra, Sandyla Leite de Sousa, Guilherme Tertuliano Silva Macedo, Igor Thiago Pinheiro Passos, Luiz De Moura Correia Filho, Cedric Maia Muribeca, Lucas Pereira de Carvalho , Giovana Sardi de Freitas Alvarez Lopes, Gisella Maria Santos Pereira , Lorenna Kellyne Rodrigues Baldoino . TRATAMENTO DA ÚLCERA GÁSTRICA RELACIONADA AO HELICOBACTER PYLORI: ABORDAGENS CIRÚRGICAS E CONSERVADORAS - UMA REVISÃO BIBLIOGRÁFICA. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218 2024; 5(4): e545103 doi: 10.47820/recima21.v5i4.5103
13
Isabel Casanovas Moreno-Torres. Encyclopedia of Infection and Immunity. 2022; : 685 doi: 10.1016/B978-0-12-818731-9.00103-8
14
Jyh‐Chin Yang, John Y. Kao. Treatment considerations in Helicobacter pylori management. Alimentary Pharmacology & Therapeutics 2022; 55(S1) doi: 10.1111/apt.16652
15
Hyasinta Jaka, Andreas Mueller, Christa Kasang, Stephen E. Mshana. Predictors of triple therapy treatment failure among H. pylori infected patients attending at a tertiary hospital in Northwest Tanzania: a prospective study. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4085-1
16
Wenxiu Zhang, Zaofeng Yang, Jiale Zheng, Kaili Fu, Jack Ho Wong, Yunbi Ni, Tzi Bun Ng, Chi Hin Cho, Michael K. Chan, Marianne M. Lee. A Bioresponsive Genetically Encoded Antimicrobial Crystal for the Oral Treatment of Helicobacter Pylori Infection. Advanced Science 2023; 10(30) doi: 10.1002/advs.202301724
17
Qian Luo, Na Liu, Sugui Pu, Ze Zhuang, Hang Gong, Dekui Zhang. A review on the research progress on non-pharmacological therapy of Helicobacter pylori. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1134254
18
Seung Min Shin, Yun Jeong Lim, Yeo Jin Yoon, Hyoun Woo Kang, Jae Hak Kim, Jun Kyu Lee, Moon-Su Koh, Jin Ho Lee. Recent First Line Eradication Rate ofHelicobacter pyloriInfection: Single Center Experience. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015; 15(2): 108 doi: 10.7704/kjhugr.2015.15.2.108
19
Kevin Pak, Zachary Junga, Andrew Mertz, Manish Singla. The Patterns and Associated Cost of Serologic Testing for Helicobacter pylori in the U.S. Military Health System. Military Medicine 2020; 185(9-10): e1417 doi: 10.1093/milmed/usaa141
20
Jyh-Chin Yang, Chun-Jung Lin, Hong-Long Wang, Jin-De Chen, John Y. Kao, Chia-Tung Shun, Chien-Wei Lu, Bor-Ru Lin, Ming-Jium Shieh, Ming-Chu Chang, Yu-Ting Chang, Shu-Chen Wei, Lin-Chih Lin, Wen-Chun Yeh, Jen-Shin Kuo, Chien-Chih Tung, Yew-Loong Leong, Teh-Hong Wang, Jau-Min Wong. High-dose Dual Therapy Is Superior to Standard First-line or Rescue Therapy for Helicobacter pylori Infection. Clinical Gastroenterology and Hepatology 2015; 13(5): 895 doi: 10.1016/j.cgh.2014.10.036
21
Yuan-Yuan Dai, Chun Qin, Gan-Rong Huang, Yan-Chun Qin, Yong-Yi Huang, Yan-Qiang Huang, Li-juan Zhao. Linolenic Acid-Metronidazole: a Compound Relieving Drug Resistance and Inhibiting Helicobacter pylori. Antimicrobial Agents and Chemotherapy 2022; 66(7) doi: 10.1128/aac.00073-22
22
Yuichiro Noiri, Ryoko Nagata. Current status of gastric and oral infection/diseases caused by Helicobacter pylori. Oral Science International 2023; 20(3): 182 doi: 10.1002/osi2.1172
23
Ayman Fathy El Sayed, Ayman Magd Eldin Mohammad Sadek, Walid Ahmed Ragab Abdelhamid. Comparison between Hybrid, Reverse Hybrid, and Non-Bismuth Levofloxacin Quadruple Regimens for Helicobacter Pylori Infection in Egypt: A Randomized Trial. Middle East Journal of Digestive Diseases 2021; 13(3): 223 doi: 10.34172/mejdd.2021.229
24
Carlos L. Arteaga, Peter C. Adamson, Jeffrey A. Engelman, Margaret Foti, Richard B. Gaynor, Susan G. Hilsenbeck, Paul J. Limburg, Scott W. Lowe, Elaine R. Mardis, Scott Ramsey, Timothy R. Rebbeck, Andrea L. Richardson, Eric H. Rubin, George J. Weiner. AACR Cancer Progress Report 2014. Clinical Cancer Research 2014; 20(19_Supplement): S1 doi: 10.1158/1078-0432.CCR-14-2123
25
Paula Parreira, Belinda I.G. Soares, Carmen S.R. Freire, Armando J.D. Silvestre, Celso A. Reis, M. Cristina L. Martins, Maria F. Duarte. Eucalyptus spp. outer bark extracts inhibit Helicobacter pylori growth: in vitro studies. Industrial Crops and Products 2017; 105: 207 doi: 10.1016/j.indcrop.2017.05.012
26
Ronita De, Avijit Sarkar, Prachetash Ghosh, Mou Ganguly, Bipul Chandra Karmakar, Dhira Rani Saha, Aniket Halder, Abhijit Chowdhury, Asish K Mukhopadhyay. Antimicrobial activity of ellagic acid against Helicobacter pylori isolates from India and during infections in mice. Journal of Antimicrobial Chemotherapy 2018; 73(6): 1595 doi: 10.1093/jac/dky079
27
Luana Kauany de Sá Santos, Jonathan Santos Apolonio, Beatriz Rocha Cuzzuol, Bruna Teixeira da Costa, Vinícius Lima de Souza Gonçalves, Ronaldo Teixeira da Silva Júnior, Marcel Silva Luz, Fabian Fellipe Bueno Lemos, Samuel Luca Rocha Pinheiro, Fabrício Freire de Melo. <i>Helicobacter pylori</i> infection in pregnant women: Gastrointestinal symptoms and pregnancy- related disorders. World Journal of Clinical Infectious Diseases 2023; 13(5): 49-57 doi: 10.5495/wjcid.v13.i5.49
28
Cheng-Jung Yao, Shu-Jyuan Yang, Chung-Huan Huang, Yuan-Ting Chang, Chung-Hao Wang, Ming-Jium Shieh, Tai-Horng Young. Retention Time Extended by Nanoparticles Improves the Eradication of Highly Antibiotic-Resistant Helicobacter pylori. Pharmaceutics 2022; 14(10): 2117 doi: 10.3390/pharmaceutics14102117
29
Zheyu Wang, Fen Wang. Efficacy and safety comparison of Helicobacter pylori eradication between vonoprazan dual therapy versus triple therapy: a systematic review and meta-analysis. Therapeutic Advances in Gastroenterology 2022; 15: 175628482211253 doi: 10.1177/17562848221125308
30
Vanessa Baratta, Jason Own, Chiara Di Renzo, Jenna Ollodart, John P. Geibel, Maria Barahona. In Pursuit of the Parietal Cell – An Evolution of Scientific Methodology and Techniques. Frontiers in Physiology 2019; 10 doi: 10.3389/fphys.2019.01497
31
Amin Talebi Bezmin Abadi. Vaccine against <i>Helicobacter pylori</i>: Inevitable approach. World Journal of Gastroenterology 2016; 22(11): 3150-3157 doi: 10.3748/wjg.v22.i11.3150
32
Shuang Zhang, Yu Wang, Fang Lu, Shadi A. D. Mohammed, Hanxing Liu, Song Ding, Shu-min Liu. Mechanism of Action of Shenerjiangzhi Formulation on Hyperlipidemia Induced by Consumption of a High-Fat Diet in Rats Using Network Pharmacology and Analyses of the Gut Microbiota. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.745074
33
Kashif Piracha. H. Pylori. 2022;  doi: 10.1007/978-3-031-10250-9_1
34
Mohsen Razavizadeh, Abbas Arj, Maryam Madani, Hamidreza Gilassi. Comparing the Efficacy of Sequential and Standard Quadruple Therapy for Eradication of H. Pylori Infection. Acta Medica (Hradec Kralove, Czech Republic) 2020; 63(4): 183 doi: 10.14712/18059694.2020.61
35
Thomas Regnath, Olaf Raecke, Axel Enninger, Ralf Ignatius. Increasing metronidazole and rifampicin resistance of Helicobacter pylori isolates obtained from children and adolescents between 2002 and 2015 in southwest Germany. Helicobacter 2017; 22(1) doi: 10.1111/hel.12327
36
Li-Wei Chen, Liang-Che Chang, Chung-Ching Hua, Ching-Jung Liu, Tien-Shin Chou, Chih-Lang Lin, Rong-Nan Chien. The Application of High-Dose Proton Pump Inhibitor Induction Treatment before Dual Therapy for Helicobacter pylori Eradication: An Open-Label Random Trial. Journal of Clinical Medicine 2021; 10(19): 4352 doi: 10.3390/jcm10194352
37
Carlotta F. ZIZZI, Rinaldo PELLICANO, Luigi BIANCONE. The relationship between Helicobacter pylori and chronic kidney disease: update 2020. Minerva Gastroenterologica e Dietologica 2021; 66(4) doi: 10.23736/S1121-421X.20.02729-4
38
Roberto Grosso, M.-Violante de-Paz. Scope and Limitations of Current Antibiotic Therapies against Helicobacter pylori: Reviewing Amoxicillin Gastroretentive Formulations. Pharmaceutics 2022; 14(7): 1340 doi: 10.3390/pharmaceutics14071340
39
Anastasia Dmitrieva, Oksana Kozlova, Victor Atuchin, Irina Milentieva, Anna Vesnina, Svetlana Ivanova, Lyudmila Asyakina, Alexander Prosekov. Study of the Effect of Baicalin from Scutellaria baicalensis on the Gastrointestinal Tract Normoflora and Helicobacter pylori. International Journal of Molecular Sciences 2023; 24(15): 11906 doi: 10.3390/ijms241511906
40
Darsh Gautam, Poonam Talwan, Sahil Dhiman, Rahul Gill, Aparna Thakur, Simran Dhiman, Deexa Sharma, Akhil Kumar, Saksham Sharma. Amoxicillin-loaded Nanotechnological Carriers for the Effective Treatment of Helicobacter pylori Infection. Micro and Nanosystems 2023; 15(4): 245 doi: 10.2174/0118764029259927231127094657
41
WonGun Kwack, YunJeong Lim, ChiYeon Lim, David Y. Graham. High Dose Ilaprazole/Amoxicillin as First-Line Regimen forHelicobacter pyloriInfection in Korea. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/1648047
42
Chunxi Shu, Zhou Xu, Cong He, Xinbo Xu, Yanan Zhou, Baihui Cai, Yin Zhu. Application of biomaterials in the eradication of Helicobacter pylori: A bibliometric analysis and overview. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1081271
43
Majid Eslami, Bahman Yousefi, Parviz Kokhaei, Ali Jazayeri Moghadas, Bizhan Sadighi Moghadam, Vahid Arabkari, Zohreh Niazi. Are probiotics useful for therapy of Helicobacter pylori diseases?. Comparative Immunology, Microbiology and Infectious Diseases 2019; 64: 99 doi: 10.1016/j.cimid.2019.02.010
44
Yu Wang, Jiang Du, Xuemei Wu, Ahmed Abdelrehem, Yu Ren, Chao Liu, Xuan Zhou, Sinan Wang. Crosstalk between autophagy and microbiota in cancer progression. Molecular Cancer 2021; 20(1) doi: 10.1186/s12943-021-01461-0
45
Javier P. Gisbert. Optimization Strategies Aimed to Increase the Efficacy of Helicobacter pylori Eradication Therapies with Quinolones. Molecules 2020; 25(21): 5084 doi: 10.3390/molecules25215084
46
Maurício Palmeira Chaves de Souza, Bruna Almeida Furquim de Camargo, Larissa Spósito, Giovanna Capaldi Fortunato, Gabriela Corrêa Carvalho, Gabriel Davi Marena, Andréia Bagliotti Meneguin, Taís Maria Bauab, Marlus Chorilli. Highlighting the use of micro and nanoparticles based-drug delivery systems for the treatment of Helicobacter pylori infections. Critical Reviews in Microbiology 2021; 47(4): 435 doi: 10.1080/1040841X.2021.1895721
47
Lynne V McFarland, Ying Huang, Lin Wang, Peter Malfertheiner. Systematic review and meta-analysis: Multi-strain probiotics as adjunct therapy forHelicobacter pylorieradication and prevention of adverse events. United European Gastroenterology Journal 2016; 4(4): 546 doi: 10.1177/2050640615617358
48
Mingyang Yu, Rongguang Zhang, Peng Ni, Shuaiyin Chen, Guangcai Duan, Rosa del Campo. Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials. PLOS ONE 2019; 14(10): e0223309 doi: 10.1371/journal.pone.0223309
49
Shu-Jyuan Yang, Chung-Huan Huang, Jyh-Chin Yang, Chung-Hao Wang, Ming-Jium Shieh. Residence Time-Extended Nanoparticles by Magnetic Field Improve the Eradication Efficiency ofHelicobacter pylori. ACS Applied Materials & Interfaces 2020; 12(49): 54316 doi: 10.1021/acsami.0c13101
50
Zain Sharif, Muaz Mubashir, Mehdi Naqvi, Hassan Atique, Saira Mahmood, Muneeb Ullah. Randomized Clinical Trial on the Efficacy of Triple Therapy Versus Sequential Therapy in Helicobacter pylori Eradication. Cureus 2022;  doi: 10.7759/cureus.24897
51
Abbas Arj, Marzieh Mollaei, Mohsen Razavizadeh, Alireza Moraveji. The comparison of levofloxacin- and clarithromycin-based bismuth quadruple therapy regimens in Helicobacter pylori eradication. Journal of Research in Pharmacy Practice 2020; 9(2): 101 doi: 10.4103/jrpp.JRPP_19_86
52
Yanchun Gao, Ruihong Wang, Lin Liu, Shitao Feng, Xiaozhi Xi, Wengong Yu, Yuchao Gu, Ye Wang. Identification and characterization of shark VNARs targeting the Helicobacter pylori adhesin HpaA. Artificial Cells, Nanomedicine, and Biotechnology 2023; 51(1): 509 doi: 10.1080/21691401.2023.2255635
53
Zhi-Ning Ye, Harry Hua-Xiang Xia, Ran Zhang, Lan Li, Li-Hao Wu, Xu-Juan Liu, Wen-Rui Xie, Xing-Xiang He, Fa-Ming Zhang. The Efficacy of Washed Microbiota Transplantation on Helicobacter pylori Eradication: A Pilot Study. Gastroenterology Research and Practice 2020; 2020: 1 doi: 10.1155/2020/8825189
54
Kamila Goderska, Sonia Agudo Pena, Teresa Alarcon. Helicobacter pylori treatment: antibiotics or probiotics. Applied Microbiology and Biotechnology 2018; 102(1): 1 doi: 10.1007/s00253-017-8535-7
55
Li Yang, Aitian Li, Ying Wang, Yi Zhang. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy. Signal Transduction and Targeted Therapy 2023; 8(1) doi: 10.1038/s41392-022-01304-4
56
Pratsanee Hiengrach, Wimonrat Panpetch, Ariya Chindamporn, Asada Leelahavanichkul. Helicobacter pylori, Protected from Antibiotics and Stresses Inside Candida albicans Vacuoles, Cause Gastritis in Mice. International Journal of Molecular Sciences 2022; 23(15): 8568 doi: 10.3390/ijms23158568
57
SubratKumar Bhattamisra, LeePeng Hooi, LaiPey Shyan, LeeBoon Chieh, Mayuren Candasamy, PriyadarshiSoumyaranjan Sahu. Effect of geraniol and clarithromycin combination against gastric ulcers induced by acetic acid and Helicobacter pylori in rats. Pharmacognosy Research 2019; 11(4): 356 doi: 10.4103/pr.pr_21_19
58
Kuang Yunle, Wu Tong, Liu Jiyang, Wu Guojun. Advances in Helicobacter pylori vaccine research: From candidate antigens to adjuvants—A review. Helicobacter 2024; 29(1) doi: 10.1111/hel.13034
59
Shu-Peng Zou, Qian Cheng, Cheng-Yang Feng, Chan Xu, Ming-Hui Sun. Comparative effectiveness of first-line therapies for eradication of antibiotic-resistant <i>Helicobacter pylori</i> strains: A network meta-analysis. World Journal of Clinical Cases 2022; 10(35): 12959-12970 doi: 10.12998/wjcc.v10.i35.12959
60
Ruiyu Wang, Shu Huang, Peiling Gan, Xiao Pan, Ping Wang, Xiaolin Zhong, Muhan Lü, Xian Zhou, Xiaowei Tang. States and hotspots in Helicobacter pylori research from 2002 to 2021: A bibliometric analysis. Helicobacter 2023; 28(4) doi: 10.1111/hel.12986
61
Lyudmila Boyanova, Ivailo Evstatiev, Daniel Yordanov, Rumyana Markovska, Ivan Mitov. Three unsuccessful treatments of Helicobacter pylori infection by a highly virulent strain with quadruple antibiotic resistance. Folia Microbiologica 2016; 61(4): 307 doi: 10.1007/s12223-015-0439-2
62
Corinne Raïssa Ngnameko, Frederic Nico Njayou, Muinah Fowora, Fredy Brice Simo Nemg, Paul Moundipa Fewou, Stella Ifeanvi Smith. Inhibitory effect of medicinal plants from Cameroon on the growth and adhesion of Helicobacter pylori. European Journal of Integrative Medicine 2019; 30: 100957 doi: 10.1016/j.eujim.2019.100957
63
Uriel Gomez-Ramirez, Pedro Valencia-Mayoral, Sandra Mendoza-Elizalde, Juan Rafael Murillo-Eliosa, Fortino Solórzano Santos, Araceli Contreras-Rodríguez, Gerardo Zúñiga, Pamela Aguilar-Rodea, Verónica Leticia Jiménez-Rojas, Juan Carlos Vigueras Galindo, Marcela Salazar-García, Norma Velázquez-Guadarrama. Role of Helicobacter pylori and Other Environmental Factors in the Development of Gastric Dysbiosis. Pathogens 2021; 10(9): 1203 doi: 10.3390/pathogens10091203
64
Wen-Juan Yang, He-Ping Zhao, Yan Yu, Ji-Han Wang, Lei Guo, Jun-Ye Liu, Jie Pu, Jing Lv. Updates on global epidemiology, risk and prognostic factors of gastric cancer. World Journal of Gastroenterology 2023; 29(16): 2452-2468 doi: 10.3748/wjg.v29.i16.2452
65
György Miklós Buzás. Helicobacter pylori– 2014. Orvosi Hetilap 2015; 156(6): 203 doi: 10.1556/OH.2015.30097
66
Ki-Young Lee, Bong-Jin Lee. Solution NMR studies onHelicobacter pyloriproteins for antibiotic target discovery. Expert Opinion on Drug Discovery 2016; 11(7): 681 doi: 10.1080/17460441.2016.1189411
67
Paulina Ortiz-Ramírez, Beatriz Hernández-Ochoa, Daniel Ortega-Cuellar, Abigail González-Valdez, Víctor Martínez-Rosas, Laura Morales-Luna, Roberto Arreguin-Espinosa, Rosa Angélica Castillo-Rodríguez, Luis Miguel Canseco-Ávila, Noemi Cárdenas-Rodríguez, Verónica Pérez de la Cruz, Alba Mónica Montiel-González, Fernando Gómez-Chávez, Saúl Gómez-Manzo. Biochemical and Kinetic Characterization of the Glucose-6-Phosphate Dehydrogenase from Helicobacter pylori Strain 29CaP. Microorganisms 2022; 10(7): 1359 doi: 10.3390/microorganisms10071359
68
Zan Wang, Shu-Li Shao, Xiao-Han Xu, Xue Zhao, Ming-Yi Wang, Ai Chen, Hai-Yan Cong. Helicobacter pyloriand gastric microbiota homeostasis: progress and prospects. Future Microbiology 2023; 18(2): 137 doi: 10.2217/fmb-2022-0102
69
Cristina Maria Marginean, Ramona Cioboata, Mihai Olteanu, Corina Maria Vasile, Mihaela Popescu, Alin Iulian Silviu Popescu, Simona Bondari, Denisa Pirscoveanu, Iulia Cristina Marginean, George Alexandru Iacob, Mihai Daniel Popescu, Mihaela Stanciu, Paul Mitrut. The Importance of Accurate Early Diagnosis and Eradication in Helicobacter pylori Infection: Pictorial Summary Review in Children and Adults. Antibiotics 2022; 12(1): 60 doi: 10.3390/antibiotics12010060
70
Hye Yoon Park, Eun Jeong Kang, Dong Gun Kim, Ki Ju Kim, Jin Woo Choi, Su Youn Nam, Yong Hwan Kwon, Hyun Seok Lee, Seong Woo Jeon. High and Frequent Dose of Dexlansoprazole and Amoxicillin Dual Therapy for Helicobacter pylori Infections: A Single Arm Prospective Study. Korean Journal of Gastroenterology 2017; 70(4): 176 doi: 10.4166/kjg.2017.70.4.176
71
Marcello Fiorani, Ege Tohumcu, Livio Enrico Del Vecchio, Serena Porcari, Giovanni Cammarota, Antonio Gasbarrini, Gianluca Ianiro. The Influence of Helicobacter pylori on Human Gastric and Gut Microbiota. Antibiotics 2023; 12(4): 765 doi: 10.3390/antibiotics12040765
72
Javier P. Gisbert, Adrian G. McNicholl. Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies. Helicobacter 2017; 22(4) doi: 10.1111/hel.12392
73
Osamah Ahmad Hakami, Refah Asheer Alsubaie, Bayan Abdulhadi Albaqami, Haifa Matar Almutlaq, Nourah Mushabab Alqahtani, Manal Alkhonezan, Farah Fahad Almuqrin, Abdullah Hussien Alghamdi, Abdullah Abdulaziz Alaryni, Rayan Abubakker Qutob. Knowledge and Perception of Physicians of Different Specialties in Saudi Arabia Toward Helicobacter pylori. Journal of Multidisciplinary Healthcare 2023; : 763 doi: 10.2147/JMDH.S403999
74
Uriel Gomez-Ramirez, Carolina G. Nolasco-Romero, Araceli Contreras-Rodríguez, Gerardo Zuñiga, Sandra Mendoza-Elizalde, Francisco-Javier Prado-Galbarro, Fernando Pérez Aguilar, Jonatan Elihu Pedraza Tinoco, Pedro Valencia-Mayoral, Norma Velázquez-Guadarrama. Dysbiosis by Eradication of Helicobacter pylori Infection Associated with Follicular Gastropathy and Pangastropathy. Microorganisms 2023; 11(11): 2748 doi: 10.3390/microorganisms11112748
75
Santino Caserta, Claudia Genovese, Nicola Cicero, Sebastiano Gangemi, Alessandro Allegra. The Anti-Cancer Effect of Cinnamon Aqueous Extract: A Focus on Hematological Malignancies. Life 2023; 13(5): 1176 doi: 10.3390/life13051176
76
NohaMahmoud Elkhodary, KhaledAbdalkader Farrag, AmanyMahmoud Elokaby, GamalAbd El-Hay Omran. Efficacy and safety of 7 days versus 10 days triple therapy based on levofloxacin-dexlansoprazole for eradication of Helicobacter pylori: A pilot randomized trial. Indian Journal of Pharmacology 2020; 52(5): 356 doi: 10.4103/ijp.IJP_364_19
77
Huili Shen, Yijie Chen, Xiaohui Li, Jing Yan, Junjie Zhao, Demin Kong, Yanxia Shi, Zhihui Li, Jihong Wang, Na Shao, Zhenghui Wang, Xueliang Wu. Impact of Helicobacter pylori Infection and Outcome of Anti-Helicobacter pylori Therapy in Patients with Reflux Laryngopharyngitis. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/8266321
78
Michael G. Bruce, Dana Bruden, Deidra Newbrough, Debby A. Hurlburt, Thomas W. Hennessy, Julie M. Morris, Alisa L. Reasonover, Frank Sacco, Brian J. McMahon. The relationship between previous antimicrobial use, antimicrobial resistance and treatment outcome among Alaskans treated forHelicobacter pyloriinfection. GastroHep 2019;  doi: 10.1002/ygh2.352
79
Hammad Ullah, Alessandro Di Minno, Cristina Santarcangelo, Haroon Khan, Jianbo Xiao, Carla Renata Arciola, Maria Daglia. Vegetable Extracts and Nutrients Useful in the Recovery from Helicobacter pylori Infection: A Systematic Review on Clinical Trials. Molecules 2021; 26(8): 2272 doi: 10.3390/molecules26082272
80
Yu Wang, Jiong Tang, Su Zhou, Tian-Tian Liang, Fang-Fang Wang, Hong Ning. Effectiveness and Safety of Rifaximin-Containing Regimens for Helicobacter pylori Eradication: Systematic Review – Are They Potential Eradication Regimens?. Infection and Drug Resistance 2022; : 3733 doi: 10.2147/IDR.S371131
81
Venkatesh Panthangi, Adrienne R Cyril Kurupp, Anjumol Raju, Gaurav Luthra, Mahrukh Shahbaz, Halah Almatooq, Paul Foucambert, Faith D Esbrand, Sana Zafar, Safeera Khan. Association Between Helicobacter pylori Infection and the Risk of Pancreatic Cancer: A Systematic Review Based on Observational Studies. Cureus 2022;  doi: 10.7759/cureus.28543
82
Mahnaz Shahabimehr, Masoud Alebouyeh, Nastaran Farzi, Arash Mahboubi, Reza Taslimi, Mohammad Reza Zali. Resistance Rate and Minimum Inhibitory Concentration of Metronidazole Among Helicobacter pylori Strains in Tehran, Iran. Archives of Clinical Infectious Diseases 2016; 11(2) doi: 10.5812/archcid.34478
83
Chi-Tan Hu. High-dose dual therapy versus bismuth-containing quadruple therapy for the treatment of Helicobacter pylori infection – A review of the strengths, weaknesses, and proposed solutions. Tzu Chi Medical Journal 2022; 34(3): 303 doi: 10.4103/tcmj.tcmj_185_21
84
Daniela Lopes-de-Campos, Catarina Leal Seabra, Rita M. Pinto, Mateusz Adam Słowiński, Bruno Sarmento, Cláudia Nunes, M. Cristina L. Martins, Salette Reis. Targeting and killing the Ever-Challenging ulcer bug. International Journal of Pharmaceutics 2022; 617: 121582 doi: 10.1016/j.ijpharm.2022.121582
85
Malek Zihlif, Banan Bashaireh, Mohammed Rashid, Zaid Almadani, Yazun Jarrar. Effect of major CYP2C19 genetic polymorphisms on Helicobacter pylori eradication based on different treatment regimens. Biomedical Reports 2021; 16(1) doi: 10.3892/br.2021.1485
86
Chia-Jung Kuo, Chun-Wei Chen, Puo-Hsien Le, Jun-Te Hsu, Cheng-Yu Lin, Hao-Tsai Cheng, Ming-Yao Su, Chun-Jung Lin, Cheng-Tang Chiu. Efficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections. Therapeutic Advances in Gastroenterology 2019; 12: 175628481987096 doi: 10.1177/1756284819870960
87
Kaifei Xu, Shuo Sheng, Feng Zhang. Relationship Between Gut Bacteria and Levodopa Metabolism. Current Neuropharmacology 2023; 21(7): 1536 doi: 10.2174/1570159X21666221019115716
88
Thukten Chophel, Sangay Tshering, Namkha Dorji, Ugyen Tshomo. Stomach Cancer Screening Services of Bhutan. Indian Journal of Surgery 2023; 85(3): 489 doi: 10.1007/s12262-022-03519-9
89
I-Ting Wu, Seng-Kee Chuah, Chen-Hsiang Lee, Chih-Ming Liang, Lung-Sheng Lu, Yuan-Hung Kuo, Yi-Hao Yen, Ming-Luen Hu, Yeh-Pin Chou, Shih-Cheng Yang, Chung-Mou Kuo, Chung-Huang Kuo, Chun-Chih Chien, Yu-Shao Chiang, Shue-Shian Chiou, Tsung-Hui Hu, Wei-Chen Tai. Five-year sequential changes in secondary antibiotic resistance of <italic>Helicobacter pylori</italic> in Taiwan. World Journal of Gastroenterology 2015; 21(37): 10669-10674 doi: 10.3748/wjg.v21.i37.10669
90
Muhammad Miftahussurur, Yoshio Yamaoka. Appropriate First-Line Regimens to Combat Helicobacter pylori Antibiotic Resistance: An Asian Perspective. Molecules 2015; 20(4): 6068 doi: 10.3390/molecules20046068
91
Hidetaka Okubo, Junichi Akiyama, Masao Kobayakawa, Megumi Kawazoe, Saori Mishima, Yusuke Takasaki, Naoyoshi Nagata, Takayuki Shimada, Chizu Yokoi, Shiori Komori, Kana Kimura, Yuya Hisada, Eri Iwata, Kazuhiro Watanabe, Naohiro Yanagisawa, Sho Shiroma, Akira Shimomura, Koki Okahara, Hourin Cho, Naomi Uemura. Vonoprazan-based triple therapy is effective for Helicobacter pylori eradication irrespective of clarithromycin susceptibility. Journal of Gastroenterology 2020; 55(11): 1054 doi: 10.1007/s00535-020-01723-6
92
Merve Öztekin, Birsen Yılmaz, Duygu Ağagündüz, Raffaele Capasso. Overview of Helicobacter pylori Infection: Clinical Features, Treatment, and Nutritional Aspects. Diseases 2021; 9(4): 66 doi: 10.3390/diseases9040066
93
Tianxing Lin, Lei Huang, Ningna Cheng, Yuzhen Wang, Zhen Ning, Shaokang Huang, Yuanhua Wu, Tianbao Chen, Songkun Su, Yan Lin. The in vitro and in vivo antibacterial activities of uniflorous honey from a medicinal plant, Scrophularia ningpoensis Hemsl., and characterization of its chemical profile with UPLC-MS/MS. Journal of Ethnopharmacology 2022; 296: 115499 doi: 10.1016/j.jep.2022.115499
94
Masoud Keikha, Parvin Askari, Kiarash Ghazvini, Mohsen Karbalaei. Levofloxacin-based therapy as an efficient alternative for eradicating Helicobacter pylori infection in Iran: a systematic review and meta-analysis. Journal of Global Antimicrobial Resistance 2022; 29: 420 doi: 10.1016/j.jgar.2021.10.019
95
Ying Liang, Jiaqian Yan, Ziqi Chen, Qing Gu, Ping Li. Antibacterial Effects of Bacteriocin PLNC8 against Helicobacter pylori and Its Potential Mechanism of Action. Foods 2022; 11(9): 1235 doi: 10.3390/foods11091235
96
Julio Valle Muñoz, Pablo Muñoz Gómez, Cristian Sierra Bernal, Eva de Andrés , César Gómez Hernando, Rafael Gómez Rodríguez. Tailored Helicobacter pylori eradication based on prior intake of macrolide antibiotics allows the use of triple therapy with optimal results in an area with high clarithromycin resistance. Revista Española de Enfermedades Digestivas 2019; 111 doi: 10.17235/reed.2019.6198/2019
97
Man-Li Zhang, Yu-Xin Fan, Rui Meng, Wen-Ke Cai, Sun-Jun Yin, Tao Zhou, Yan-Hua Huang, Ping Wang, Fang-Fang Jiang, Mei Yang, Gong-Hao He. Proton Pump Inhibitors and Cancer Risk. American Journal of Clinical Oncology 2022; 45(11): 475 doi: 10.1097/COC.0000000000000949
98
Ghazal Mohseni, Juan Li, Abakundana Nsenga Ariston Gabriel, Lutao Du, Yun-shan Wang, Chuanxin Wang. The Function of cGAS-STING Pathway in Treatment of Pancreatic Cancer. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.781032
99
Mayo Hirabayashi, Manami Inoue, Norie Sawada, Eiko Saito, Sarah K. Abe, Akihisa Hidaka, Motoki Iwasaki, Taiki Yamaji, Taichi Shimazu, Shoichiro Tsugane. Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-42365-w
100
Guangqin Xu, Shaoze Ma, Liyan Dong, Nahum Mendez-Sanchez, Hongyu Li, Xingshun Qi, Alessandro Granito. Relationship of Helicobacter pylori Infection with Nonalcoholic Fatty Liver Disease: A Meta-Analysis. Canadian Journal of Gastroenterology and Hepatology 2023; 2023: 1 doi: 10.1155/2023/5521239
101
Guang-Hong Jheng, I-Chen Wu, Hsiang-Yao Shih, Meng-Chieh Wu, Fu-Chen Kuo, Huang-Ming Hu, Chung-Jung Liu, Wen-Hung Hsu, Chi-Tan Hu, Ming-Jong Bair, Chao-Hung Kuo, Deng-Chyang Wu, Ping-I Hsu. Comparison of Second-Line Quadruple Therapies with or without Bismuth forHelicobacter pyloriInfection. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/163960
102
Pei Zhou, Yawen Hu, Xiaoyan Wang, Luxuan Shen, Xinghao Liao, Yajuan Zhu, Jiadong Yu, Fulei Zhao, Yi Zhou, Hengshui Shen, Jiong Li. Microbiome in cancer: An exploration of carcinogenesis, immune responses and immunotherapy. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.877939
103
John Y. Kao, June S. Almenoff, Dana D. Portenier, Kely L. Sheldon. Helicobacter pylori eradication by low‐dose rifabutin triple therapy (RHB‐105) is unaffected by high body mass index . GastroHep 2021; 3(7): 426 doi: 10.1002/ygh2.494
104
Tugce Gur Maz, H. Burak Caliskan, Irfan Capan, Burcu Caliskan, Berrin Özçelik, Erden Banoglu. Design, Synthesis and Evaluation of Aryl‐Tailored Oxadiazole‐thiones as New Urease Inhibitors. ChemistrySelect 2023; 8(8) doi: 10.1002/slct.202204449
105
Ummay Mahfuza Shapla, Jinat Raihan, Asiful Islam, Fahmida Alam, Naeem Solayman, Siew Hua Gan, Sakib Hossen, Ibrahim Khalil. Propolis: The future therapy against Helicobacter pylori-mediated gastrointestinal diseases. Journal of Applied Biomedicine 2018; 16(2): 81 doi: 10.1016/j.jab.2017.10.007
106
Qian Hu, Ze Peng, Lingli Li, Xin Zou, Lijun Xu, Jing Gong, Ping Yi. The Efficacy of Berberine-Containing Quadruple Therapy on Helicobacter Pylori Eradication in China: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Frontiers in Pharmacology 2020; 10 doi: 10.3389/fphar.2019.01694
107
Furui Zhang, Linhan Ni, Zhen Zhang, Xuegang Luo, Xuequan Wang, Wenmiao Zhou, Jiale Chen, Jing Liu, Yuliang Qu, Kunmei Liu, Le Guo. Recombinant L. lactis vaccine LL-plSAM-WAE targeting four virulence factors provides mucosal immunity against H. pylori infection. Microbial Cell Factories 2024; 23(1) doi: 10.1186/s12934-024-02321-4
108
Yujia Ke, Cheng Tan, Junhai Zhen, Weiguo Dong. Global status and trends of gastric cancer and gastric microbiota research: a bibliometric analysis. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1341012
109
Meng-Shu Hsieh, Fu-Chen Kuo, Meng-Chieh Wu, Jiunn-Wei Wang, Chung-Jung Liu, Neng-Sheng Chu, Pei-Yun Tsai, Ping-I Hsu, I-Chen Wu, Jeng-Yih Wu, Deng-Chyang Wu, Fang-Jung Yu, Chao-Hung Kuo. Tailored susceptibility-guided therapy via gastric juice PCR for the first-line H. pylori eradication, a randomized controlled trial. Journal of the Formosan Medical Association 2022; 121(8): 1450 doi: 10.1016/j.jfma.2021.10.011
110
M. Xia, H. Chen, S. Liu. The synergy of resveratrol and alcohol against Helicobacter pylori and underlying anti‐ Helicobacter pylori mechanism of resveratrol . Journal of Applied Microbiology 2020; 128(4): 1179 doi: 10.1111/jam.14531
111
Vincent J. Venditto, David J. Feola. Delivering macrolide antibiotics to heal a broken heart – And other inflammatory conditions. Advanced Drug Delivery Reviews 2022; 184: 114252 doi: 10.1016/j.addr.2022.114252
112
Mariel de Barros, Luisa Mota da Silva, Thaise Boeing, Lincon Bordignon Somensi, Benhur Judah Cury, Ligia de Moura Burci, José Roberto Santin, Sérgio Faloni de Andrade, Franco Delle Monache, Valdir Cechinel-Filho. Pharmacological reports about gastroprotective effects of methanolic extract from leaves of Solidago chilensis (Brazilian arnica) and its components quercitrin and afzelin in rodents. Naunyn-Schmiedeberg's Archives of Pharmacology 2016; 389(4): 403 doi: 10.1007/s00210-015-1208-0
113
Hauberline Domegne Mikwangock, Alfred Ngenge Tamfu, André Perfusion Amang, Gael Tchokomeni Siwe, Christophe Mezui, Selcuk Kucukaydin, Enonchong George Enow-Orock, Paul Vernyuy Tan, Valeria Pasciu. Chronic Gastric Ulcer Healing Actions of the Aqueous Extracts of Staple Plant Foods of the North-West, Adamawa, and West Regions of Cameroon. BioMed Research International 2023; 2023: 1 doi: 10.1155/2023/2657278
114
Satoru Mizutani, Yu Takahashi, Takeshi Shimamoto, Hideki Nakagawa, Hiroyuki Hisada, Kaori Oshio, Dai Kubota, Hiroya Mizutani, Daisuke Ohki, Yoshiki Sakaguchi, Seiichi Yakabi, Keiko Niimi, Naomi Kakushima, Yosuke Tsuji, Ryoichi Wada, Nobutake Yamamichi, Mitsuhiro Fujishiro. Performing the ABC Method Twice for Gastric Cancer Risk Stratification: A Retrospective Study Based on Data from a Large-Scale Screening Facility. Diagnostics 2023; 13(7): 1284 doi: 10.3390/diagnostics13071284
115
Anam Naz, Tahreem Zaheer, Hamza Arshad Dar, Faryal Mehwish Awan, Ayesha Obaid, Shifa Tariq Ashraf, Rehan Zafar Paracha, Arif Malik, Amjad Ali. A Multi-Method and Structure-Based In Silico Vaccine Designing Against Helicobacter pylori Employing Immuno-Informatics Approach. Current Proteomics 2021; 18(2): 237 doi: 10.2174/1570164617999200414120231
116
Hongjin Tao, Fansen Meng, Yu Zhou, Jiao Fan, Jing Liu, Yingjie Han, Benjamin B. Sun, Gangshi Wang, Jennifer Gaddy. Transcriptomic and Functional Approaches Unveil the Role of tmRNA in Zinc Acetate Mediated Levofloxacin Sensitivity in Helicobacter pylori. Microbiology Spectrum 2022; 10(6) doi: 10.1128/spectrum.01152-22
117
Mengjuan Xuan, Xinyu Gu, Yingru Liu, Li Yang, Yi Li, Di Huang, Juan Li, Chen Xue. Intratumoral microorganisms in tumors of the digestive system. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-023-01425-5
118
Muhammad Miftahussurur, Yoshio Yamaoka. Helicobacter pylori Research. 2016; : 519 doi: 10.1007/978-4-431-55936-8_23
119
Li Cen, Jiaqi Pan, Boyan Zhou, Chaohui Yu, Youming Li, Weixing Chen, Zhe Shen. Helicobacter Pylori infection of the gallbladder and the risk of chronic cholecystitis and cholelithiasis: A systematic review and meta‐analysis. Helicobacter 2018; 23(1) doi: 10.1111/hel.12457
120
Nathan E. Agbor, Seraphine N. Esemu, Lucy M. Ndip, Nicoline F. Tanih, Stella I. Smith, Roland N. Ndip. Helicobacter pylori in patients with gastritis in West Cameroon: prevalence and risk factors for infection. BMC Research Notes 2018; 11(1) doi: 10.1186/s13104-018-3662-5
121
Maliheh Safavi, Reyhaneh Sabourian, Alireza Foroumadi. Treatment of <i>Helicobacter pylori</i> infection: Current and future insights. World Journal of Clinical Cases 2016; 4(1): 5-19 doi: 10.12998/wjcc.v4.i1.5
122
Bumjo Oh, Bong‐Soo Kim, Ji Won Kim, Jong Seung Kim, Seong‐Joon Koh, Byeong Gwan Kim, Kook Lae Lee, Jongsik Chun. The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial. Helicobacter 2016; 21(3): 165 doi: 10.1111/hel.12270
123
Mark A. Moyad. Integrative Medicine for Breast Cancer. 2016; : 343 doi: 10.1007/978-3-319-23422-9_8
124
Soo Yeon Choi, Na Rae Lim, Woo Chul Chung. Tailored Therapy Using Bismuth Add-on Standard Triple Therapy vs. Concomitant Therapy: A First-line Regimen for Helicobacter pylori Infection. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2023; 23(2): 118 doi: 10.7704/kjhugr.2022.0058
125
Jacek Budzyński. Helicobacter pylori eradication: Not only early consequences. EBioMedicine 2018; 35: 8 doi: 10.1016/j.ebiom.2018.08.051
126
Saumya Das, Manas Kumar Das, Rajashree Das, Valentina Gehlot, Shweta Mahant, Papiya Mitra Mazumder, Sanjita Das, Neha Falls, Vikas Kumar. Isolation, characterization of Berberine from Berberis aristata DC for eradication of resistant Helicobacter pylori. Biocatalysis and Agricultural Biotechnology 2020; 26: 101622 doi: 10.1016/j.bcab.2020.101622
127
Shuanghui Luo, Wei Liu, Zhiqin Zeng, Feng Ye, Chupeng Hu, Ningyin Xu, An Huang, Tao Xi, Yingying Xing. Toxic adjuvants alter the function and phenotype of dendritic cells to initiate adaptive immune responses induced by oral Helicobacter pylori vaccines. Helicobacter 2018; 23(6) doi: 10.1111/hel.12536
128
Freya Wellhöner, Nico Döscher, Tammo Lambert Tergast, Marius Vital, Iris Plumeier, Silke Kahl, Andrej Potthoff, Michael Peter Manns, Benjamin Maasoumy, Heiner Wedemeyer, Markus Cornberg, Dietmar Helmut Pieper, Benjamin Heidrich. The impact of proton pump inhibitors on the intestinal microbiota in chronic hepatitis C patients. Scandinavian Journal of Gastroenterology 2019; 54(8): 1033 doi: 10.1080/00365521.2019.1647280
129
Colin W. Howden, Stuart J. Spechler, Michael F. Vaezi, A. Mark Fendrick, Christian Atkinson, Corey Pelletier, Rinu Jacob, Stephen Brunton. Study of Acid-related Disorders: Real-world Physician and Patient Perspectives on Burden of Helicobacter pylori Infection. Gastro Hep Advances 2022; 1(2): 231 doi: 10.1016/j.gastha.2021.12.005
130
Fraser Smith. Naturopathic Medicine. 2022; : 225 doi: 10.1007/978-3-031-13388-6_8
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345